Lipsky Rachele, Potts Essie M, Tarzami Sima T, Puckerin Akil A, Stocks Joanne, Schecter Alison D, Sobie Eric A, Akar Fadi G, Diversé-Pierluissi María A
Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, New York 10029, USA.
J Biol Chem. 2008 Jun 20;283(25):17221-6. doi: 10.1074/jbc.C800061200. Epub 2008 May 5.
Voltage-dependent calcium channels (VDCCs) play a pivotal role in normal excitation-contraction coupling in cardiac myocytes. These channels can be modulated through activation of beta-adrenergic receptors (beta-ARs), which leads to an increase in calcium current (I(Ca-L)) density through cardiac Ca(v)1 channels as a result of phosphorylation by cAMP-dependent protein kinase A. Changes in I(Ca-L) density and kinetics in heart failure often occur in the absence of changes in Ca(v)1 channel expression, arguing for the importance of post-translational modification of these channels in heart disease. The precise molecular mechanisms that govern the regulation of VDCCs and their cell surface localization remain unknown. Our data show that sustained beta-AR activation induces internalization of a cardiac macromolecular complex involving VDCC and beta-arrestin 1 (beta-Arr1) into clathrin-coated vesicles. Pretreatment of myocytes with pertussis toxin prevents the internalization of VDCCs, suggesting that G(i/o) mediates this response. A peptide that selectively disrupts the interaction between Ca(V)1.2 and beta-Arr1 and tyrosine kinase inhibitors readily prevent agonist-induced VDCC internalization. These observations suggest that VDCC trafficking is mediated by G protein switching to G(i) of the beta-AR, which plays a prominent role in various cardiac pathologies associated with a hyperadrenergic state, such as hypertrophy and heart failure.
电压依赖性钙通道(VDCCs)在心肌细胞正常的兴奋-收缩偶联中起关键作用。这些通道可通过β-肾上腺素能受体(β-ARs)的激活进行调节,由于环磷酸腺苷(cAMP)依赖性蛋白激酶A的磷酸化作用,这会导致通过心脏Ca(v)1通道的钙电流(I(Ca-L))密度增加。心力衰竭时I(Ca-L)密度和动力学的变化通常在Ca(v)1通道表达无变化的情况下发生,这表明这些通道的翻译后修饰在心脏病中具有重要意义。控制VDCCs调节及其细胞表面定位的精确分子机制仍不清楚。我们的数据表明,持续的β-AR激活会诱导一种涉及VDCC和β-抑制蛋白1(β-Arr1)的心脏大分子复合物内化到网格蛋白包被的囊泡中。用百日咳毒素预处理心肌细胞可防止VDCCs的内化,这表明G(i/o)介导了这种反应。一种选择性破坏Ca(V)1.2与β-Arr1之间相互作用的肽以及酪氨酸激酶抑制剂能够轻易阻止激动剂诱导的VDCC内化。这些观察结果表明,VDCC的转运是由β-AR向G(i)蛋白转换介导的,这在与高肾上腺素能状态相关的各种心脏疾病(如肥大和心力衰竭)中起重要作用。